123-92-2

Applied Filters:

Keyword:'123-92-2'

Showing 1-30 of 168 results for "123-92-2" within Technical Documents

Acad. Sci. USA., 92(19), 8813- 7 (1995). 2. Drees, F. et al., Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell, 123(5), 903-15 (2005

Quality Control Ranges: Human Angiogenesis/ Growth Factor Magnetic Bead Panel 1

Control 2 1764 – 3664 pg/mL Control 2 432– 896 pg/mL Endothelin-1 Control 1 59 – 123 pg/mL VEGF-D Control 1 110 – 229 pg/mL

Anti-a-Catenin-Biotin antibody produced in rabbit (B6184)

, 10759-10761 (1994). 5. Tsukita S., et al., J. Cell Biol., 123, 1049-1053 (1993). 6. Bradley, R., et al., J. Cell Biol., 123, 1857-1865 (1993). 7. Hinck, L., et al., J. Cell Biol.

Specification Sheet: NovAseptic® Mixer Drive Unit, GMP ATEX

Mixer assembly type AX05/41 281 (11.06) 145 (5.71) 123 (4.84) 83 (3.27) –055 125 (4.92) –056 — — GMP50 ATEX AX1/41 281 (11.06) 145 (5.71) 123 (4.84) 71 (2.80) –057 131 (5.16) –058 171 (6.73) –059

MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors

43 27 97 15 44 26 33 29 127 27 19 12 37 8809 118 44 29 92 15 46 25 33 29 130 27 SPARC std 4 18 12 17 16 1377 41 26 92 14

User Guide (IFU) - 1.14449

- 40 mg/l de PO4-P 2) 3,1 - 6,1 - 11 - 18 - 31 - 61 - 123 mg/l de PO43- 190 2,3 - 4,6 - 8,0 - 14 - 23

Quality Control Range Sheet- A60MG-105 and A60MG-205

pg/ml Control 2 103 - 214 pg/mL Control 2 88 - 182 pg/ml IL-5 Control 1 25 - 51 pg/mL IL-22 Control1 482

User Guide

6.0 - 10 - 20 - 40 mg/l PO4-P 3.1 - 6.1 - 11 - 18 - 31 - 61 - 123 mg/l PO43- 190 2.3 - 4.6 - 8.0 - 14

Data Sheet - I9906

(1994). 2. Paschal, B.M., and Gerace, L., J. Cell Biol., 129, 925-937 (1995) 3. Moore, M.S., and Blobel, G., Nature, 365, 661-663 (1993). 4. Melchior, F., et al., J. Cell Biol., 123, 1649-1659

Data Sheet - P8087

EMBO J., 7, 3679 (1988). 6. Tsukita, S., et al., J. Cell Biol., 123, 1049 (1993). 7. Aberle, H., et al., Proc. Natl. Acad. Sci. USA, 92, 6384 (1995). DS,KAA,PHC 09/12-1

Quality Control Range Sheet- TH17-112 and TH17-212

8.2 ng/mL Control 2 135 - 281 pg/mL Control 2 35 - 73 ng/mL CCL20/MIP3α Control 1 59 – 123 pg/mL IL-5 Control 1 72 - 150

User Guide

- 6,0 - 10 - 20 - 40 mg/l PO4-P 3,1 - 6,1 - 11 - 18 - 31 - 61 - 123 mg/l PO43- 190 2,3 - 4,6 - 8,0 -

Development of Multiplex Immunoassay Panels for Simultaneous Quantification of Bone Metabolism Markers using Luminex xMAP Technology

Bone Panels: 2 Multiplex and 1 Single-plex ACCURACY (%): 1A 1B 2A 2B RANKL — — 119 78 OPG 95 90 — — Insulin 92 101 92 91 Leptin 87 93 93 93 ACTH 117 92 115 85 IL-6 86 87 89 90 TNFα 122

Product Information Sheet - F0503

Biophys. Acta, 473(2), 73-92 (1977). 6. Gaskill, H. V., Intraportal prostaglandin E1 ameliorates the toxicity of intraportal 2'-deoxy-5- fluorouridine in rats. J. Surg. Res., 43(2), 128-132 (1987)

Product Information Sheet - H3025

. Enzymol., vol. 65, 92 (1980). 2. The Merck Index, 12th Ed., Entry# 4685. 3. Sakaki, H., et al., Improved method for the immobilization of heparin. J. Chromatogr., 400, 123-132 (1987). 4. Mitra

Product Information Sheet - A2449

. Cancer J., 8(2), 82-92 (2002). 8. 8. Reutelingsperger, C.P., et al., Visualization of cell death in vivo with the annexin A5 imaging protocol. J. Immunol. Methods, 265(1-2), 123-132 (2002).

Data Sheet - C2206

Sci. USA, 91, 11989 (1994). 5. Tsukita S., et al., J. Cell Biol., 123, 1049 (1993). 6. Bradley, R., et al., J. Cell Biol., 123, 1857 (1994). 7. Hinck, L., et al., J. Cell Biol., 124, 729 (1994). 8.

Quality Control Range Sheet- PCC-124 and PCC-224

Control 1 123 - 255 pg/mL Control 2 461 - 957 pg/mL Control 2 965 - 2004 pg/mL TGFα Control 1 63 - 131 pg/mL IL-5

MultiScreen Filter Plates with Ultracel®-10 Membrane

30 38 44 BSA 125 128 122 136 115 126 124 120 Buffer 132 142 176 140 136 138 131 123 Cyto c 122 131 124 119 118 123 124 117 FBS 79 70 57 43 42 54 67 72 Human

Verfication summary-03-0202-00

71.12 1.8 2% 91% 3 37.5 36.96 0.7 2% 92% HMN108002 3 0.0 50 3.36 0.5 13% - 3 150.0 159.29 6.0 4% 104% 3 75.0 77.53 5.0 6% 99% 3 37.5

Verfication summary-03-0202-00

71.12 1.8 2% 91% 3 37.5 36.96 0.7 2% 92% HMN108002 3 0.0 50 3.36 0.5 13% - 3 150.0 159.29 6.0 4% 104% 3 75.0 77.53 5.0 6% 99% 3 37.5

Product Information Sheet - H1277

Tris-HCl, pH 7.5, with 2 M NaCl), and 1/2 column volume fractions are collected. The E0.1% at 280 nm for ATIII is 0.65. References 1. Meth. Enzymol., vol. 65, 92 (1980). 2. The Merck Index

Product Information - 54836

Tris-HCl, pH 7.5, with 2 M NaCl), and 1/2 column volume fractions are collected. The E0.1% at 280 nm for ATIII is 0.65. References 1. Meth. Enzymol., vol. 65, 92 (1980). 2. The Merck Index

Product Information - 54837

Tris-HCl, pH 7.5, with 2 M NaCl), and 1/2 column volume fractions are collected. The E0.1% at 280 nm for ATIII is 0.65. References 1. Meth. Enzymol., vol. 65, 92 (1980). 2. The Merck Index

User Guide

- 10 - 20 - 40 mg/l de PO4-P 3,1 - 6,1 - 11 - 18 - 31 - 61 - 123 mg/l de PO43- 190 2,3 - 4,6 - 8,0 -

Anti-alpha-Catenin (C2081)

Sci. USA, 91, 10759 (1994). 5. Tsukita S., et al., J. Cell Biol., 123, 1049 (1993). 6. Bradley, R., et al., J. Cell Biol., 123, 1857 (1994). 7. Hinck, L., et al., J. Cell Biol., 124, 729 (1994). 8.

User Guide

- 40 mg/l de PO4-P 2) 3,1 - 6,1 - 11 - 18 - 31 - 61 - 123 mg/l de PO43- 190 2,3 - 4,6 - 8,0 - 14 - 23

Data Sheet - P1870

Landes Company and Chapman & Hall, Austin, TX (1997). 4. Tsukita, S., et al., J. Cell Biol., 123, 1049-1053 (1993). 5. Mo, Y.Y., and Reynolds, A.B., Cancer Res., 56,

Data Sheet - P7484

Ingebritsen, T.S., and Cohen, P., Science 221, 331 (1983). 2. Shenolikar, S., and Nairn, A.C., Adv. Second Messenger Phosphoprotein 23, 123 (1991). 3. Berndt, N., et al., FEBS Lett.. 223, 340 (1987

Data Sheet - P7979

Ingebritsen, T.S., and Cohen, P., Science 221, 331 (1983). 2. Shenolikar, S., and Nairn, A.C., Adv. Second Messenger Phosphoprotein 23, 123 (1991). 3. Berndt, N., et al., FEBS Lett.. 223, 340 (1987)

Page 1 of 6